View Alert
Versions:


Originator: DHSC & NHS England and Improvement: Supply disruption alert

 
Issue date: Originally issued on 28-Apr-2020 14:52:11. This version was issued on 28-Apr-2020 14:52:11

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • NHS Trusts (England) - Medical Director
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • CMO Urgent Messages - Recipients on Public Health Link
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive
  • GP - Locum
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Primary Care Networks

Action category: Action

Title: Ativan (lorazepam) 4mg/ml solution for injection - Supply Disruption

Broadcast content:
Ativan (lorazepam) 4mg/ml solution for injection will be out of stock from w/c 27th April until w/c 15th June 2020. Please note there are attachments with this alert which the alert references.

This alert contains advice on the management of affected patients.

Given the links to covid-19 we have sent this alert to a broader mailing list than would usually receive a Supply Disruption Alert of this type. 

Note that we have updated the 'Unlicensed medicine quality assessment' attachment. This is to replace an embedded pdf link with a weblink and to correct the strength of Carpuject the document refers to.


Additional information: NHS Regional Offices: please cascade this alert to community pharmacy and any GP Practices not yet registered with CAS.

Alert reference: SDA/2020/006

Action underway deadline: 30-Apr-2020

Action complete deadline: 19-Jun-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency